Drug watch. Multiple sclerosis agents.
- Published in:
- 2010
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2010 AND VI 45 AND IP 10
Results: 12
1
2
Attention deficit hyperactivity disorder: more than a child's disease.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
FDA drug approvals. FDA actions in brief.
- Published in:
- 2010
- Publication type:
- Journal Article
4
Drug Watch. Multiple sclerosis agents.
- Published in:
- Formulary, 2010, v. 45, n. 10, p. 330
- Publication type:
- Article
5
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2010, v. 45, n. 10, p. 303
- Publication type:
- Article
6
Late-stage product development. New agent development crucial in treatment of hepatitis C.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
7
Policy Watch. CER studies will alter methods for assessing the value of new therapies and coverage calculations.
- Published in:
- Formulary, 2010, v. 45, n. 10, p. 328
- By:
- Publication type:
- Article
8
Attention deficit hyperactivity disorder: More than a child's disease.
- Published in:
- Formulary, 2010, v. 45, n. 10, p. 318
- By:
- Publication type:
- Article
9
Focus on lurasidone: A new atypical antipsychotic for the treatment of schizophrenia.
- Published in:
- Formulary, 2010, v. 45, n. 10, p. 313
- By:
- Publication type:
- Article
10
Late-stage Product Development. New agent development crucial in treatment of hepatitis C.
- Published in:
- Formulary, 2010, v. 45, n. 10, p. 305
- By:
- Publication type:
- Article
11
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2010, v. 45, n. 10, p. 304
- Publication type:
- Article
12
FDA Drug Approvals. New combinations.
- Published in:
- Formulary, 2010, v. 45, n. 10, p. 303
- Publication type:
- Article